(Q36543429)

14 August 2017

1 reference

title

Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response? (English)

1 reference

14 August 2017

1 reference

2

Gregory Y H Lip

1 reference

14 August 2017

Aun-Yeong Chong

1

1 reference

14 August 2017

publication date

21 July 2006

1 reference

European Journal of Heart Failure

14 August 2017

published in

1 reference

14 August 2017

volume

9

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

124-128

1 reference

Mode of death in heart failure: findings from the ATLAS trial

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Adhesion molecules--Part II: Blood vessels and blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Transcriptional regulation of tissue factor expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

C-reactive protein in acute myocardial infarction: association with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Vasoprotection by nitric oxide: mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Nitric oxide insufficiency, platelet activation, and arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Myocardial contractile response to nitric oxide and cGMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Nitric oxide induces caspase-dependent apoptosis and necrosis in neonatal rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Circulating endothelial cells and vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Angiopoietin-1 protects the adult vasculature against plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Protective role of angiopoietin-1 in endotoxic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Statin therapy is associated with lower mortality among patients with severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Debate: Should statin be used in patients with heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

The endotoxin-lipoprotein hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.05.009

10.1016/J.EJHEART.2006.05.009

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference